Sympathetic Overactivity in Essential Hypertension

首次发布于 2007 年 10 月 10 日

The Renin-Angiotensin System in Essential Hypertension

计划入组 11 人 · 首次发布于 2005 年 9 月 1 日

Renal Sympathetic Modification in Patients With Essential Hypertension

计划入组 200 人 · 首次发布于 2011 年 8 月 16 日

antisense therapy (essential hypertension)

Delapril

C₂₆H₃₂N₂O₅

Imidapril

C₂₀H₂₇N₃O₆ · Rx

Kidney & Hypertension Center

United States

Essential Medical, Inc.

United States

ESSENTIAL PHARMA LIMITED

Malta

Triple Drug Antihypertensive Single-Pill Combinations Added to WHO Essential Medicines List

Essential Pharma Acquires Ventavis for Primary Pulmonary Hypertension from Bayer AG

CDSCO Panel Asks Sun Pharma to Conduct Phase III Trial of Esaxerenone for Resistant Hypertension